Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone therapy in children with anorexia nervosa and severe growth retardation
2010-018560-16Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of Norditropine SimpleXx in anorexia nervosa (AN), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Linear growth velocity. Started Apr 2010; status: completed.
02
Drugs
Norditropine SimpleXx
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on 2010-018560-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018560-16.